Announcements Trials

Browse Landscape

Phase

Status

Completed 11 Terminated 2 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 7 Lymphoma 4 Neutropenia 3 Lymphoma, Large B-Cell, Diffuse 3 Testicular Neoplasms 2 Testicular Germ Cell Tumor 2 Multiple Myeloma 2 Central Nervous System Neoplasms 2 Breast Neoplasms, Male 2 Triple Negative Breast Neoplasms 1 Seminoma 1 Ovarian Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Febrile Neutropenia 1 Endodermal Sinus Tumor 1 Chemotherapy-induced Neutropenia 1

Interventions

Exercise 19 Drug Therapy 18 pembrolizumab 13 Capecitabine 11 Blood Specimen Collection 11 Surveys and Questionnaires 10 Radiotherapy 10 Paclitaxel 9 Dexamethasone 9 Nivolumab 8 Standard of Care 7 Oxaliplatin 7 Fluorouracil 7 Erlotinib Hydrochloride 7 apatinib 6 Interviews as Topic 6 Gemcitabine 6 Control Groups 6 Cisplatin 6 Therapeutics 5 Neoadjuvant Therapy 5 Mindfulness-Based Cognitive Therapy 5 Metformin 5 Injections 5 Everolimus 5 Docetaxel 5 Cyclophosphamide 5 Bevacizumab 5 sintilimab 4 atezolizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasms × pegfilgrastim × Clear all

NCT00751894 2011-01-19

MEG-5

University Hospital, Clermont-Ferrand

Phase 2 Unknown

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡